GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Motif Bio PLC (NAS:MTFB) » Definitions » EBITDA Margin %

Motif Bio (Motif Bio) EBITDA Margin % : 0.00% (As of Dec. 2020)


View and export this data going back to 2016. Start your Free Trial

What is Motif Bio EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Motif Bio's EBITDA for the six months ended in Dec. 2020 was $-0.08 Mil. Motif Bio's Revenue for the six months ended in Dec. 2020 was $0.00 Mil. Therefore, Motif Bio's EBITDA margin for the quarter that ended in Dec. 2020 was 0.00%.


Motif Bio EBITDA Margin % Historical Data

The historical data trend for Motif Bio's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Motif Bio EBITDA Margin % Chart

Motif Bio Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Motif Bio Semi-Annual Data
Dec11 Dec12 Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Motif Bio's EBITDA Margin %

For the Shell Companies subindustry, Motif Bio's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Motif Bio's EBITDA Margin % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Motif Bio's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Motif Bio's EBITDA Margin % falls into.



Motif Bio EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Motif Bio's EBITDA Margin % for the fiscal year that ended in Dec. 2020 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2020 )/Revenue (A: Dec. 2020 )
=-0.734/0
= %

Motif Bio's EBITDA Margin % for the quarter that ended in Dec. 2020 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2020 )/Revenue (Q: Dec. 2020 )
=-0.084/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Motif Bio  (NAS:MTFB) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Motif Bio EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Motif Bio's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Motif Bio (Motif Bio) Business Description

Traded in Other Exchanges
N/A
Address
3-7 Temple Avenue, 201 Temple Chambers, London, GBR, EC4Y 0DT
Motif Bio PLC is a cash shell company.

Motif Bio (Motif Bio) Headlines

From GuruFocus

Motif Bio plc AGM Statement

By Marketwired Marketwired 05-22-2019

Motif Bio Receives Complete Response Letter from the FDA

By Marketwired Marketwired 02-14-2019

Motif Bio Confirms Receipt of Deficiency Notice from Nasdaq

By Marketwired Marketwired 07-26-2019

Motif Bio Announces Receipt of Deficiency Notice from Nasdaq

By Marketwired Marketwired 07-19-2019

Motif Bio Confirms Meeting Date with U.S. FDA regarding Iclaprim

By Marketwired Marketwired 07-26-2019

Motif Bio Presents New Iclaprim Data at IDWeek

By Marketwired Marketwired 10-03-2018

Motif Bio Presents New Iclaprim Data at ECCMID 2019

By Marketwired Marketwired 04-16-2019

Motif Bio Granted Meeting with U.S. FDA regarding Iclaprim

By Marketwired Marketwired 03-20-2019

Motif Bio plc: Notice of Annual General Meeting

By Marketwired Marketwired 04-26-2019